| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 李蔚 | 中航证券 | 医药生物 | 35.20% | 39.51% | 34.05% | 0.00% | 7 | -49.52% | 2025-07-29 |
| 2 | 胡博新 | 华鑫证券 | 医药生物 | 35.19% | 39.17% | 35.62% | -6.38% | 3 | -51.98% | 2025-07-17 |
| 3 | 刘浩 | 华创证券 | 医药生物 | 35.12% | 7.97% | 1.48% | 20.00% | 1 | -47.33% | 2023-12-29 |
| 4 | 华挺 | 财通证券 | 医药生物 | 35.12% | 36.24% | 11.18% | -6.67% | 7 | -50.33% | 2025-07-15 |
| 5 | 阳景 | 浦银国际证券 | 医药生物 | 35.08% | 32.27% | 14.12% | 100.00% | 4 | 0.00% | 2025-06-16 |
| 6 | 周豫 | 太平洋 | 医药生物 | 35.07% | 41.74% | 26.66% | 20.00% | 23 | -55.62% | 2025-07-15 |
| 7 | 韩世通 | 中信证券 | 医药生物 | 35.05% | 40.82% | 31.60% | -8.70% | 6 | -63.25% | 2025-07-09 |
| 8 | 王斌 | 首创证券 | 医药生物 | 35.05% | 38.89% | 21.40% | -3.03% | 19 | -54.62% | 2025-07-25 |
| 9 | 吴春红 | 江海证券 | 医药生物 | 34.94% | 18.19% | 20.58% | 27.27% | 7 | -25.67% | 2025-06-04 |
| 10 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 34.80% | 44.01% | 41.65% | 3.45% | 2 | -27.10% | 2025-04-11 |
| 11 | 仰佳佳 | 申万宏源 | 医药生物 | 34.79% | 9.75% | -2.98% | 16.67% | 1 | -37.64% | 2025-08-04 |
| 12 | 阳景 | 浦银国际证券 | 医药生物 | 34.79% | 41.01% | 21.10% | 100.00% | 4 | 0.00% | 2025-07-09 |
| 13 | 杨松 | 天风证券 | 医药生物 | 34.78% | 37.34% | 24.70% | -45.36% | 19 | -72.65% | 2025-07-25 |
| 14 | 李华云 | 长城证券 | 医药生物 | 34.76% | 29.04% | 17.21% | -7.69% | 7 | -33.32% | 2023-12-29 |
| 15 | 周豫 | 太平洋 | 医药生物 | 34.73% | 39.87% | 26.70% | 20.00% | 23 | -55.62% | 2025-07-14 |
| 16 | 吴春红 | 江海证券 | 医药生物 | 34.73% | 36.32% | 9.11% | 27.27% | 5 | -25.67% | 2025-07-31 |
| 17 | 李安飞 | 广发证券 | 医药生物 | 34.70% | 21.76% | 30.26% | 2.86% | 1 | -56.96% | 2025-05-12 |
| 18 | 张林晚 | 上海证券 | 医药生物 | 34.70% | 39.38% | 22.68% | -100.00% | 1 | -18.93% | 2025-07-03 |
| 19 | 刘浩 | 华创证券 | 医药生物 | 34.62% | 34.33% | 32.23% | 20.00% | 2 | -47.33% | 2025-05-19 |
| 20 | 周豫 | 太平洋 | 医药生物 | 34.58% | 41.73% | 28.89% | 20.00% | 23 | -55.62% | 2025-07-16 |